AF
ACTU

Allworth Financial’s Actuate Therapeutics ACTU Stock Holding History

Allworth Financial’s Portfolio ACTU Stock Details ACTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$110 Buy
+40
New +$166 ﹤0.01% 5000

Other funds holding ACTU

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allworth Financial's ACTU Position: Q1 2026 in Review

Allworth Financial opened a new position in Actuate Therapeutics (ACTU) in Q1 2026: 40 shares worth $110. The stake represents ﹤0.01% of the portfolio and ranks #5000 among its holdings.

61 funds tracked by Wall St. Rank hold ACTU as of Q1 2026.

  • Allworth Financial held 40 shares of Actuate Therapeutics worth $110 as of Q1 2026.
  • Actuate Therapeutics was a new Allworth Financial position in Q1 2026.
  • Actuate Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #5000 holding.
  • 61 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.